COMPARISON OF THE EFFECTIVENESS OF CENTCHROMAN AND NORETHISTERONE IN THE TREATMENT OF HEAVY MENSTRUAL BLEEDING

Not Applicable

• Conditions: Health Condition 1: N925- Other specified irregular menstruation

• Registration Number: CTRI/2024/07/069801
• Lead Sponsor: ANGANA DAS

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Women with heavy menstrual bleeding with or without associated dysmenorrhea or chronic pelvic pain

2.All women with histologically proven endometrial hyperplasia without atypia or any other benign endometrial pathology

3.Fibroid uterus less than 12 weeks in size not distorting the endometrial cavity

4.Adenomyosis

5.All women with medical or surgical high risk factors making the subjects unsuitable for surgery

Exclusion Criteria

1.Active genital infection

2.Suspicion of pregnancy or malignancy

3.Submucosal fibroid distorting the endometrial cavity

4.Uterine fibroids more than 5 centimeters in size

5.Atypical endometrial hyperplasia or malignancy

6.Abnormal cervical cytology and malignancy

7.Haematological disease or abnormal coagulopathy

8.History of arterial or venous thromboembolic disorders

9.Women who want to conceive

10.Women who are not willing to give consent for the study

11.Patients with polycystic ovarian disease or history of jaundice or hepatic impairment or severe allergy or tuberculosis or renal impairment or undiagnosed vaginal bleeding or breast cancer

Study & Design

• Study Type: Interventional
• Study Design: Not specified